Distribution of human papillomavirus genotypes in women with high-grade cervical intraepithelial lesions and cervical carcinoma and analysis of human papillomavirus-16 genomic variants.


Journal

Croatian medical journal
ISSN: 1332-8166
Titre abrégé: Croat Med J
Pays: Croatia
ID NLM: 9424324

Informations de publication

Date de publication:
28 Feb 2021
Historique:
entrez: 4 3 2021
pubmed: 5 3 2021
medline: 28 4 2021
Statut: ppublish

Résumé

To analyze the distribution of high-risk human papillomavirus (HR-HPV) genotypes and the diversity of HPV-16 genomic variants in Croatian women with high-grade squamous intraepithelial lesions (HSIL) and cervical carcinoma. Tissue biopsy specimens were obtained from 324 women with histopathologically confirmed HSIL or cervical carcinoma, 5 women with low-grade SIL, and 49 women with negative histopathology. HR-HPV DNA was detected with Ampliquality HPV-type nucleic-acid hybridization assay, which identifies 29 different HPV genotypes. HPV-16 genomic variants were analyzed by an in-house sequencing. The most common HPV type in women with HSIL was HPV-16, detected in 127/219 (57.9%) specimens. HPV-16 was also the dominant type in squamous cell cervical carcinoma (46/69 or 66.7%) and in adenocarcinoma (18/36 or 50.0%). Out of 378 patients, 360 had HR-HPV (282 single infections and 79 multiple infections), 3 (0.8%) patients had low-risk HPV, and 15 (4%) tested negative. HPV-16 variants were determined in 130 HPV-16 positive specimens, including 74 HSIL and 46 carcinoma specimens. In HSIL specimens, 41 distinct variants were found, 98.6% belonging to the European branch and 1.4% belonging to the African branch. In cervical carcinoma specimens, 95% isolates grouped in 41 variants belonging to the European branch, one isolate (2.5%) belonged to the North American, and one (2.5%) to the Asian-American branch. HPV-16, mainly belonging to the European branch, was the most frequent HPV genotype in women from Croatia with histologically confirmed HSIL and cervical cancer.

Identifiants

pubmed: 33660963
pmc: PMC7976879

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-79

Références

Eur J Epidemiol. 1997 Sep;13(6):645-51
pubmed: 9324210
Virology. 2009 Nov 10;394(1):8-11
pubmed: 19758676
J Natl Cancer Inst. 1997 Jun 4;89(11):796-802
pubmed: 9182978
Cancer Res. 1998 Feb 15;58(4):829-33
pubmed: 9485042
Coll Antropol. 2007 Apr;31 Suppl 2:89-96
pubmed: 17598510
Int J Cancer. 1999 Nov 12;83(4):449-55
pubmed: 10508478
J Virol. 1992 Apr;66(4):2057-66
pubmed: 1312620
J Gen Virol. 2004 Jun;85(Pt 6):1433-1444
pubmed: 15166426
J Virol. 1995 Dec;69(12):7743-53
pubmed: 7494284
J Clin Microbiol. 2008 Mar;46(3):1060-6
pubmed: 18199779
Cent Eur J Public Health. 2013 Mar;21(1):26-9
pubmed: 23741896
Expert Rev Anti Infect Ther. 2010 Oct;8(10):1139-62
pubmed: 20954880
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482
Coll Antropol. 2007 Apr;31 Suppl 2:79-82
pubmed: 17598509
PLoS One. 2017 Jul 10;12(7):e0180480
pubmed: 28692681
J Virol. 1997 Mar;71(3):2463-72
pubmed: 9032384
Syst Biol. 2008 Oct;57(5):758-71
pubmed: 18853362
J Med Virol. 2003 Apr;69(4):546-52
pubmed: 12601763
J Gen Virol. 2000 Feb;81(Pt 2):317-25
pubmed: 10644829
J Med Virol. 2008 Dec;80(12):2134-40
pubmed: 19040290
Br J Cancer. 2002 Jan 21;86(2):269-73
pubmed: 11870518
Int J Cancer. 2001 Dec 1;94(5):711-6
pubmed: 11745467
Coll Antropol. 2007 Apr;31 Suppl 2:83-7
pubmed: 17600936
Int J Cancer. 2006 Mar 1;118(5):1071-6
pubmed: 16331617
Infect Genet Evol. 2015 Aug;34:44-51
pubmed: 26160543
Lancet Oncol. 2010 Nov;11(11):1048-56
pubmed: 20952254
Biotechniques. 2007 Jul;43(1):58, 60, 62
pubmed: 17695253
J Med Virol. 2004 Sep;74(1):117-26
pubmed: 15258977
Coll Antropol. 2007 Apr;31 Suppl 2:73-7
pubmed: 17598508
J Virol Methods. 2009 Dec;162(1-2):142-7
pubmed: 19664661
J Gen Virol. 2000 Dec;81(Pt 12):2959-2968
pubmed: 11086127
Swiss Med Wkly. 2017 Nov 29;147:w14559
pubmed: 29185245
Mod Pathol. 2019 Jul;32(8):1189-1196
pubmed: 30911077
Dis Markers. 2007;23(4):213-27
pubmed: 17627057
Int J Cancer. 2013 Feb 15;132(4):854-67
pubmed: 22752992
J Obstet Gynaecol Res. 2010 Dec;36(6):1204-13
pubmed: 21114573
Eur J Cancer. 2000 Jul;36(11):1402-10
pubmed: 10899654
J Med Virol. 2014 Apr;86(4):618-26
pubmed: 24150786
J Virol. 2005 May;79(10):5914-22
pubmed: 15857977
Coll Antropol. 2013 Dec;37(4):1179-83
pubmed: 24611331
Int J Cancer. 1999 Jul 19;82(2):203-7
pubmed: 10389753
Bioinformatics. 2010 Aug 1;26(15):1899-900
pubmed: 20427515
J Natl Cancer Inst. 2001 Feb 21;93(4):315-8
pubmed: 11181779

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH